Prophylactic and antinociceptive effects of coenzyme q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes

Anesthesiology

Volumn 118, Issue 4, 2013, Pages 945-954

  Zhang, Yan Ping ^a   Eber, Ariel ^a   Yuan, Yue ^a   Yang, Zhe ^a   Rodriguez, Yiliam ^a,b   Levitt, Roy C ^a   Takacs, Peter ^a   Candiotti, Keith A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COQ10; GLUCOSE; UBIDECARENONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HYPERALGESIA; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; REVERSE TRANSCRIPTION; SCIATIC NERVE; SPINAL GANGLION; STREPTOZOCIN DIABETES; WEIGHT REDUCTION;

ANALGESICS; ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UBIQUINONE; VITAMINS; WEIGHT LOSS;

EID: 84875898962     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182829b7b     Document Type: Article

References (42)

1. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM: Diabetic somatic neuropathies. Diabetes Care 2004; 27:1458-86
2. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D; American Diabetes Association: Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005; 28:956-62
3. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U: Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 2004; 110:628-38
4. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116:109-18
5. Habib AA, Brannagan TH 3rd: Therapeutic strategies for diabetic neuropathy. Curr Neurol Neurosci Rep 2010; 10:92-100
6. Várkonyi T, Kempler P: Diabetic neuropathy: New strategies for treatment. Diabetes Obes Metab 2008; 10:99-108
7. Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54:1615-25
8. Schmeichel AM, Schmelzer JD, Low PA: Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003; 52:165-71
9. Vincent AM, Russell JW, Low P, Feldman EL: Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004; 25:612-28
10. White FA, Bhangoo SK, Miller RJ: Chemokines: Integrators of pain and inflammation. Nat Rev Drug Discov 2005; 4:834-44
11. Mémet S: NF-kappaB functions in the nervous system: From development to disease. Biochem Pharmacol 2006; 72:1180-95
12. Niederberger E, Geisslinger G: The IKK-NF-kappaB pathway: A source for novel molecular drug targets in pain therapy? FASEB J 2008; 22:3432-42
13. Fu ES, Zhang YP, Sagen J, Yang ZQ, Bethea JR: Transgenic glial nuclear factor-kappa B inhibition decreases formalin pain in mice. Neuroreport 2007; 18:713-7
14. Fu ES, Zhang YP, Sagen J, Candiotti KA, Morton PD, Liebl DJ, Bethea JR, Brambilla R: Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain 2010; 148:509-18
15. Gao YJ, Ji RR: Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 2010; 126:56-68
16. Turunen M, Olsson J, Dallner G: Metabolism and function of coenzyme Q. Biochim Biophys Acta 2004; 1660:171-99
17. Sun IL, Sun EE, Crane FL, Morré DJ, Lindgren A, Löw H: Requirement for coenzyme Q in plasma membrane electron transport. Proc Natl Acad Sci USA 1992; 89:11126-30
18. Belardinelli R, Tiano L, Littarru GP: Oxidative stress, endothelial function and coenzyme Q10. Biofactors 2008; 32:129-33
19. Kunitomo M, Yamaguchi Y, Kagota S, Otsubo K: Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci 2008; 107:128-37
20. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD: Coenzyme Q10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 2002; 56:1137-42
21. Wyman M, Leonard M, Morledge T: Coenzyme Q10: A therapy for hypertension and statin-induced myalgia? Cleve Clin J Med 2010; 77:435-42
22. Salles JE, Moisés VA, Almeida DR, Chacra AR, Moisés RS: Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10. Diabetes Res Clin Pract 2006; 72:100-3
23. Ayaz M, Tuncer S, Okudan N, Gokbel H: Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: Conduction velocity distributions. Methods Find Exp Clin Pharmacol 2008; 30:367-74
24. Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. FASEB J 2008; 22:659-61
25. Vincent AM, McLean LL, Backus C, Feldman EL: Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 2005; 19:638-40
26. Calcutt NA, Cooper ME, Kern TS, Schmidt AM: Therapies for hyperglycaemia-induced diabetic complications: From animal models to clinical trials. Nat Rev Drug Discov 2009; 8:417-29
27. Rao AV, Balachandran B: Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2002; 5:291-309
28. Obrosova IG: How does glucose generate oxidative stress in peripheral nerve? Int Rev Neurobiol 2002; 50:3-35
29. Rao AV, Balachandran B: Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2002; 5:291-309
30. Lin MT, Beal MF: Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443:787-95
31. Harrison JF, Hollensworth SB, Spitz DR, Copeland WC, Wilson GL, LeDoux SP: Oxidative stress-induced apoptosis in neurons correlates with mitochondrial DNA base excision repair pathway imbalance. Nucleic Acids Res 2005; 33:4660-71
32. Meunier A, Latrémolière A, Dominguez E, Mauborgne A, Philippe S, Hamon M, Mallet J, Benoliel JJ, Pohl M: Lentiviralmediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol Ther 2007; 15:687-97
33. Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ: Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 2001; 21:5027-35
34. Suzuki S, Hinokio Y, Ohtomo M, Hirai M, Hirai A, Chiba M, Kasuga S, Satoh Y, Akai H, Toyota T: The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 1998; 41:584-8
35. Hamilton SJ, Chew GT, Watts GF: Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care 2009; 32:810-2
36. Feigin A, Kieburtz K, Como P, Hickey C, Claude K, Abwender D, Zimmerman C, Steinberg K, Shoulson I: Assessment of coenzyme Q10 tolerability in Huntington's disease. Mov Disord 1996; 11:321-3
37. Beal MF, Shults CW: Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease. Biofactors 2003; 18:153-61
38. Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K: Safety assessment of coenzyme Q10 (CoQ10). Biofactors 2008; 32:199-208
39. Williams KD, Maneke JD, AbdelHameed M, Hall RL, Palmer TE, Kitano M, Hidaka T: 52-Week oral gavage chronic toxicity study with ubiquinone in rats with a 4-week recovery. J Agric Food Chem 1999; 47:3756-63
40. Kunitomo M, Yamaguchi Y, Kagota S, Otsubo K: Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci 2008; 107:128-37
41. Sohet FM, Neyrinck AM, Pachikian BD, de Backer FC, Bindels LB, Niklowitz P, Menke T, Cani PD, Delzenne NM: Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol 2009; 78:1391-400
42. Choi BS, Song HS, Kim HR, Park TW, Kim TD, Cho BJ, Kim CJ, Sim SS: Effect of coenzyme Q10 on cutaneous healing in skin-incised mice. Arch Pharm Res 2009; 32:907-13